Robert T. Naismith
Abstract
Neuromyelitis optica (NMO) is a distinct autoimmune disease, typically characterized by aquaporin-4 (AQP4) antibodies, which are associated with
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Neuromyelitis optica (NMO) is a distinct autoimmune disease, typically characterized by aquaporin-4 (AQP4) antibodies, which are associated with
Key concepts: Medicine, Neuromyelitis optica, Targeted therapy, Multiple sclerosis, Internal medicine, Immunology, Cancer